Toggle Dropdown
Announcements
Projects
News & Events
Welcome guest
Log in
Loading
Loading...
https://www.news-medical.net/news/20221006/The-immune-responses-and-safety-of-fractional-third-doses-of-heterologous-COVID-19-vaccines-after-CoronaVac-primary-series.aspx
0
0
The immune responses and safety of fractional third-doses of heterologous COVID-19 vaccines after CoronaVac primary series - News-Medical.Net
10/6/22 at 11:45am
Organization
News-Medical.Net
46 words
0
Comments
Researchers evaluated the vaccine effectiveness of half-doses of AZD1222 or BNT162b2 COVID-19 vaccines as a booster dose following primary series vaccination with CoronaVac.
Infectious Diseases
general
third-doses
half-doses
CoronaVac
BNT162b2 COVID
Covishield
You are the first to view
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...